Allarity Therapeutics Inc
Research Allarity Therapeutics Inc (ALLR) on Bullrun: market cap USD 20.68M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALLR
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 20.68M
- Financial periodFY2025
- RevenueUSD 320.00K
- Net income-USD 11.23M
- Free cash flow-USD 14.83M
Valuation Snapshot
latest market cap is USD 20.68M.
About Allarity Therapeutics Inc
Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology.
Frequently asked questions
What is Allarity Therapeutics Inc's market cap?
Allarity Therapeutics Inc's market capitalization is USD 20.68M.
What does Allarity Therapeutics Inc do?
Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States.